3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
31
Lung Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
5
Ovarian Neoplasms
5
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Retinoblastoma
2
Neoplasms
2
Neoplasm Metastasis
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous-Cell Lung Cancer
1
Sjogren's Syndrome
1
Scleroderma, Systemic
1
Retinal Neoplasms
1
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
1
Resectable Non-small Cell Lung Cancer
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrence
1
Psoriasis
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Oropharyngeal Neoplasms
1
Nonsquamous Non-small Cell Lung Cancer
1
Non-Squamous Non-Small Cell Lung Cancer
1
NSCLC
1
Multiple Sclerosis
1
Melanoma
1
Lymphatic Metastasis
1
Interventions
Etoposide
3
Carboplatin
3
Vincristine
2
Topotecan
1
Platinum Compounds
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Eye Enucleation
1
Drug Therapy
1
Doxorubicin
1
Cyclophosphamide
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Retinal Neoplasms
×
Platinum Compounds
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled